Open AccessTopical therapy for pyoderma
Author(s) -
А. В. Самцов
Publication year - 2020
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/vdv1167-2020-96-5-59-64
Subject(s) - pyoderma , mupirocin , medicine , pyoderma gangrenosum , dermatology , epidemiology , antibiotics , disease , intensive care medicine , staphylococcus aureus , microbiology and biotechnology , methicillin resistant staphylococcus aureus , biology , bacteria , genetics
The article is of an overview nature. It provides various classifications of pyoderma and infections of the skin and soft tissues, epidemiological data on pyoderma in our country and abroad, discusses in detail local and systemic risk factors for the development of the disease, environmental risk factors. Much attention is paid to comparative studies on the efficacy and safety of mupirocin (Supirocin) in comparison with systemic antibiotics and topical antibacterial agents, indicating the benefits of mupirocin.